Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
22,12 USD | +1,14% | -0,94% | -27,71% |
Attività
Numero di dipendenti: 525
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Drugs
100,0
%
| 243 | 100,0 % | 241 | 100,0 % | -1,03% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 243 | 100,0 % | 241 | 100,0 % | -1,03% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 54 | 01/12/07 | |
Director of Finance/CFO | 57 | 01/01/09 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Patrick O'brien
CMP | Compliance Officer | 60 | 01/12/14 |
Bruce Given
COO | Chief Operating Officer | 69 | 26/10/11 |
Vincent Anzalone
IRC | Investor Relations Contact | - | - |
Aaron Tan
AUD | Comptroller/Controller/Auditor | - | 01/07/21 |
Nadia Meshkova
TRE | Treasurer | - | - |
Tracie Oliver
PRN | Corporate Officer/Principal | 62 | 01/06/22 |
Matt Pulisic
PRN | Corporate Officer/Principal | - | 01/08/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 23/11/10 |
Michael Perry
BRD | Director/Board Member | 64 | 19/12/11 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 01/09/20 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 01/04 |
Chief Executive Officer | 54 | 01/12/07 | |
William Waddill
BRD | Director/Board Member | 67 | 01/01/18 |
Mauro Ferrari
BRD | Director/Board Member | 64 | 19/08/10 |
Director/Board Member | 60 | 02/05/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 123 896 914 | 118 333 484 ( 95,51 %) | 0 | 95,51 % |
Coordinate società
Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard Suite 700
91105, Pasadena
+626 304 3400
http://www.arrowheadpharma.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-27,71% | 2,74 Mrd | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione ARWR
- Società Arrowhead Pharmaceuticals, Inc.